Nadda inaugurated the Affordable Medicines and Reliable Implants for Treatment (AMRIT) outlet at Safdarjung Hospital.
The AMRIT retail outlets will sell drugs at highly discounted rates and have a very comprehensive list of medicines that are available across range of products.
Nine AMRIT Pharmacies have been set up and Safdarjung Hospital is the tenth of this kind, Nadda said.
"More than 195 drugs for treatment of cancer and 186 drugs for treatment of Cardiovascular Diseases are being sold through AMRIT with a discount of more than 90 per cent are available to patients," he said.
"We are planning to open 300 outlets in the country. AMRIT pharmacy reflects our strong commitment to reduce the cost of treatment for the patients," he said.
The project has been floated in a tie-up with government-owned HLL Lifecare Ltd (HLL) which is mandated to establish and run the AMRIT chain of pharmacies across the country.
HLL has said that the value of drugs dispensed (till May 30) from seven outlets is around Rs 7 crore while the MRP for the same was Rs 20 crore.
"The State Governments have been informed about the AMRIT Pharmacies and have been advised to consider opening such pharmacies,"he said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
